Neoadjuvant PRRT With 177Lu-DOTATATE Followed by Surgery for Resectable PanNET
NCT04385992
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
177Lu-Dotatate
Sponsor
IRCCS San Raffaele